Alastin Skincare Announces Appointment of Amber Edwards as Chief Commercial Officer

August 4, 2020

Alastin Skincare Inc.—a specialty aesthetics company dedicated to developing and marketing innovative, clinically tested, physician-dispensed skin care products with proprietary TriHex Technology that enhance, protect and maintain healthy skin for a lifetime—has announced the appointment of Amber Edwards to the position of chief commercial officer, effective July 31, 2020.
Edwards holds a proven track record of successful business leadership and global development of leading brands in the medical aesthetics arena. She most recently served as president of North America for Sinclair Pharma. Prior to Sinclair, she was at Allergan Inc., where she was the vice president of international strategic marketing, Medical Aesthetics Franchise, in the U.K. She also has experience with Allergan in the U.S., in both aesthetic and therapeutic areas. Edwards began her career in sales and marketing roles at Pfizer.
Read more at PR Newswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • AmSpa CEO Reflects on the Sonya Dakar Case
    • SkinStylus Receives New FDA Clearance for the Improvement of Periorbital Wrinkles for All Skin Types
    • GlossGenius Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • Medicare GLP-1 Bridge Program Launches July 1, Expanding Access for Some Patients
    • Universal Healthcare Consulting Becomes Platinum Vendor Affiliate with the American Med Spa Association